President and Chief Executive Officer
John Alexander (Alex) Martin joined Coherex Medical as President and CEO in July 2012. Mr. Martin was most recently at WorldHeart Corporation as Director, President and CEO from February 2009 to April 2012. Previously, he was at Edwards Lifesciences where he was President of the North American Region and Corporate Vice President from June 2004 to July 2008.
From 1999 to 2004 he was with Cordis Corporation, a Johnson and Johnson (J&J) company, where he served as Senior Vice President of International and prior to that, Vice President of Sales and Marketing. At Cordis, he had responsibility for all U.S. coronary therapeutic and diagnostic device sales and under his leadership the company experienced significant growth and became the market leader. Mr. Martin was responsible for the launch of the first commercialized drug-eluting stent in the US while at Cordis.
Before Cordis, Mr. Martin served in sales, marketing and business development management positions at several organizations, including C.R. Bards’ USCI division, Cambridge Heart and IMED Corporation. He also served as Director of the Emergency Medical Services at The Medical Center at Bowling Green. Mr. Martin earned a bachelor’s degree from the University of Kentucky at Lexington.
RONALD B. WATKINS
Chief Operating Officer
Mr. Watkins joined Coherex in 2007 and has over 25 years of medical device manufacturing and operational experience. Mr. Watkins began his career as a manufacturing engineer with Baxter Edwards Laboratories, working with the Carpentier-Edwards bioprosthetic heart valve. He joined Rubicon Medical in 2001 as Vice President of Operations and oversaw the merger with Boston Scientific as the Site Manager. As Site Manager, he was instrumental in the integration of the operational systems of Rubicon Medical into Boston Scientific’s systems.
He has over 10 years of experience developing early stage technology companies. He served a key role in developing engineering and manufacturing processes, implemented quality systems, and was instrumental in developing a culture of success for these companies. Mr. Watkins holds a degree in manufacturing engineering from Brigham Young University. He also has a Masters of Business Administration degree.
Vice President, Accounting and Finance
Ms. Thomas graduated with a Master of Accountancy from Brigham Young University in August 1989. She began her career with Price Waterhouse in San Francisco starting in Audit and transferring a few years later into Consulting. Ms. Thomas audit clients ran the spectrum from small, non-profit organizations, to large oil and gas corporations. As a consultant, she helped an international consumer products company implement a new accounting system. She assisted companies with IPO offerings and consulted with a large semiconductor company on a litigation project.
Ms. Thomas was invited by WordPerfect Corporation to join its company as their assistant controller and project manager to implement an Oracle full suite accounting/manufacturing system. When Novell acquired WordPerfect, she continued to work for Novell as its Financial Systems Administrator responsible for consolidating worldwide financial data using a data warehouse reporting system. In 2005, Ms. Thomas was recruited by Phone Directories Company (PDC) to relocate to Utah where she served as its Controller and project manager of an Oracle Financials implementation. In July of 2007 she assisted in the sale of PDC.
Ms. Thomas joined Coherex Medical in 2009 as its Controller and has since been promoted to VP of finance and accounting. She helped Coherex implement a new Enterprise Resource Planning (ERP) system. Ms. Thomas is a Certified Public Accountant (CPA).
DARYL R. EDMISTON
Vice President, Research and Development
Mr. Edmiston has an extensive background in engineering project management, medical device design, and state-of-the-art manufacturing processes. He has worked with leading companies in the electro-optics and semiconductor industries. As a private consultant, Mr. Edmiston advised various companies in the semiconductor and medical device manufacturing sector. He joined Rubicon Medical in 2000, serving as Director, and then Vice President of Research and Development.
At Rubicon Medical, Mr. Edmiston was instrumental in the design and development of two separate embolic protection systems including Rubicon’s Guardian embolic protection system, which was licensed to Abbott Vascular and more recently, the Rubicon Filter embolic protection system for which Rubicon Medical was purchased by Boston Scientific in 2005. He joined Coherex Medical in March 2006. Mr. Edmiston received his Bachelor of Science degree from Brigham Young University and his Masters Degree in Mechanical Engineering from Purdue University.
Vice President, Regulatory Affairs and Quality Assurance
Mr. Mathews began his career in the medical device industry with the Ethicon Division of Johnson & Johnson. As manager of regulatory affairs, he was responsible for product approval activities in the U.S. including 510(k)s, IDEs, PMAs, and PMA supplements. During his tenure at Ethicon, Mr. Mathews was appointed as HIMA (AdvaMed) Management Fellow, representing the interests of all medical device divisions of J&J through the Health Industry Manufacturers Association.
He later joined Independence Technology, a new startup within J&J and a maker of class III medical devices, as the director of Regulatory Affairs, Quality Assurance. Mr. Mathews then joined Provasis Therapeutics as Vice President, Regulatory Affairs and Quality Assurance. Provasis was a start up venture that developed a class III medical device for the treatment of aneurysms and arteriovenous malformations.
Immediately before joining Coherex Medical, Mr. Mathews was Vice President, Regulatory Affairs for Boston Scientific with responsibility for their west coast businesses including electrophysiology, neurovascular, cardiac imaging, and vascular protection. Mr. Mathews has a Masters of Science degree in Horticulture from Rutgers University.